Liu, M., Chen, Q., Zhang, L., Zhou, Y., Wen, N., Jin, J., . . . Zhao, Q. (2026). Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors. Cancer Biology & Medicine, 23(3), 392. https://doi.org/10.20892/j.issn.2095-3941.2025.0775
Chicago Style (17th ed.) CitationLiu, Mingzhu, et al. "Metabolic Engineering of SLC38A2 Reprograms Glutamine Utilization and Enhances CAR-macrophage Antitumor Function in Solid Tumors." Cancer Biology & Medicine 23, no. 3 (2026): 392. https://doi.org/10.20892/j.issn.2095-3941.2025.0775.
MLA (9th ed.) CitationLiu, Mingzhu, et al. "Metabolic Engineering of SLC38A2 Reprograms Glutamine Utilization and Enhances CAR-macrophage Antitumor Function in Solid Tumors." Cancer Biology & Medicine, vol. 23, no. 3, 2026, p. 392, https://doi.org/10.20892/j.issn.2095-3941.2025.0775.